Navigation Links
From autism to diabetes to Parkinson's disease

PHILADELPHIA (June 13, 2013)Twenty-two of the nation's most enterprising researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts today. The scholarships provide flexible funding to early-career scientists researching the basis of perplexing health problems such as diabetes, autism, Parkinson's disease, and cancer. The new scholars join a prestigious community of researchers who have gone on to become Nobel laureates, MacArthur fellows, Albert Lasker Basic Medical Research Award winners, and hundreds of other pioneers who earned Pew grants at the start of their careers.

"The Pew scholars program gives innovative scientists both the freedom to take calculated risks and the resources to pursue the most promising, but untried, avenues for scientific breakthroughs," said Rebecca W. Rimel, president and CEO of Pew. "Pew funding provides an 'insurance policy,' allowing our scientists to be adventurous with their research. Though their scientific fields are diverse, their commitment is uniform: harnessing scientific discovery to improve human health."

The scholars program, launched in 1985, has granted more than $120 million in funding to more than 500 scientists at the beginning of their independent careers. The rigorously competitive program awards recipients $240,000 over four years to pursue their projects without direction or restriction. To be considered, applicants must demonstrate excellence and creativity in their research. This year, 179 institutions were invited to nominate a candidate, and 134 eligible nominations were received.

"Now more than ever, young scientists need the support to pursue untested leads," said Craig C. Mello, Ph.D., a 1995 Pew scholar and a 2006 Nobel laureate in physiology or medicine. "I am confident that these gifted scholars will make tremendous contributions to science. Their work will provide the world with new knowledge and tools to do tomorrow what seems impossible today."

Pew also directs the Pew Latin American Fellows Program in the Biomedical Sciences, which for 22 years has provided support to young Latin American scientists receiving postdoctoral training in the United States.

The 2013 Pew biomedical scholars are:

Hillel Adesnik, Ph.D.
University of California, Berkeley

Mark Andermann, Ph.D.
Beth Israel Deaconess Medical Center

Bo Chen, Ph.D.
Yale University

Claudio Giraudo, Ph.D.
The Children's Hospital of Philadelphia
Cell biology and immunology

Andrew Goodman, Ph.D.
Yale University

Viviana Gradinaru, Ph.D.
California Institute of Technology

Sergei Grivennikov, Ph.D.
Fox Chase Cancer Center
Cancer biology and immunology

Andrew Huberman, Ph.D.
University of California, San Diego
Developmental neurobiology

Suckjoon Jun, Ph.D.
University of California, San Diego
Quantitative and physical biology

Shingo Kajimura, Ph.D.
University of California, San Francisco
Developmental biology and metabolism

Jeffrey Kidd, Ph.D.
University of Michigan

April Kloxin, Ph.D.
University of Delaware
Bioengineering and integrative biology

Fei Li, Ph.D.
New York University
Gene regulation and chromatin biology

Shelly Peyton, Ph.D.
University of Massachusetts, Amherst
Bioengineering and cancer biology

Manu Prakash, Ph.D.
Stanford University
Bioengineering and insect ecology

Avital Rodal, Ph.D.
Brandeis University

June Round, Ph.D.
University of Utah
Microbiology and immunology

Alexander Sobolevsky, Ph.D.
Columbia University
Biochemistry and molecular biophysics

Leo Wan, Ph.D.
Rensselaer Polytechnic Institute

Ilana Witten, Ph.D.
Princeton University

Qi Wu, Ph.D.
University of Iowa
Neuroscience and energy metabolism

Qiaobing Xu, Ph.D.
Tufts University


Contact: Chelsea Toledo
Pew Health Group

Related biology news :

1. Autism discovery paves way for early blood test and therapeutic options
2. Over-produced autism gene alters synapses, affects learning and behavior in mice
3. Bigger birth weight babies at greater risk of autism
4. Epigenetic changes shed light on biological mechanism of autism
5. In autism, age at diagnosis depends on specific symptoms
6. Autism in black and white: NIH grant helps scientist study disorder in African Americans
7. Atypical brain circuits may cause slower gaze shifting in infants who later develop autism
8. Folic acid lowers risk of autism
9. Speech emerges in children with autism and severe language delay at greater rate than thought
10. Ultrasound reveals autism risk at birth
11. Researcher uncovers potential cause, biomarker for autism and proposes study to investigate theory
Post Your Comments:
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/29/2015)... OXFORD, Connecticut , October 29, 2015 /PRNewswire/ ... "Company"), a biometric authentication company focused on the ... Wocket® smart wallet announces that StackCommerce, a leading ... will be featuring the Wocket® smart wallet on ... NXTD ) ("NXT-ID" or the "Company"), a ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... Kingdom , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... company, announced today that it has closed the sale ... business to Guerbet (GBT- NYSE Euronext) in a transaction ... encompassed four manufacturing facilities and a total of approximately ... in the St. Louis area. ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
Breaking Biology Technology: